The New York Genome Center received the Columbia University Medical Center and NewYork-Presbyterian Health Sciences Advisory Council (HSAC) Award for Distinguished Service at the HSAC annual meeting on October 22.
The Award, the HSAC’s highest honor, is given to individuals who have shown a strong and committed interest in health sciences and whose influence and reputation have made a significant impact on the public concerning healthcare. Previous recipients, since 1990, have included Ms. Barbara Walters, Mr. and Mrs. Robert Wright, The Honorable Edward I. Koch, Dr. Sanjay Gupta, Dr. Michael DeBakey, Mr. Derek Jeter and Mrs. Katharine Graham.
Robert Darnell, MD, PhD, President, Chief Executive Officer and Scientific Director of NYGC, accepted the award from Stuart J. Rabin, Chairman of the Council; Lee Goldman, MD, Harold and Margaret Hatch Professor of the University, Dean of the Faculties of Health Sciences and Medicine, Chief Executive, Columbia University Medical Center, Columbia University, and Andria L. Castellanos, MBA, Group Senior Vice President & Chief Operating Officer, NewYork-Presbyterian/Columbia University Medical Center.
HSAC’s mission is to increase recognition and resources for NewYork-Presbyterian/Columbia and Columbia University Medical Center’s programs in healthcare, training, research and service.
“The New York Genome Center is honored to be recognized by this Council, particularly at this meeting on cancer genomics,” said Dr. Darnell, “We are proud of our collaborations with our colleagues at Columbia and New York Presbyterian and are united in our goal of accelerating and harnessing genomic research to help diagnose and treat patients.”
The Council meeting was titled, “Cancer Genomics: Advances in Treatment” and featured presentations by Andrew Kung, MD, PhD, Chief, Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, New York-Presbyterian/Morgan Stanley Children’s Hospital; Robert and Ellen Kapito Professor of Pediatrics, Columbia University College of Physicians and Surgeons, and Gary K. Schwartz, MD, Associate Director of the Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian/Columbia University Medical Center, and Professor of Medicine and Chief of the Division of Hematology and Oncology, Columbia University College of Physicians and Surgeons.
About the New York Genome Center
The New York Genome Center (NYGC) is an independent, nonprofit at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations and partners are united in this unprecedented collaboration of technology, science, and medicine. We harness the power of innovation and discoveries to improve people’s lives – ethically, equitably, and urgently. Member institutions include: Albert Einstein College of Medicine, American Museum of Natural History, Cold Spring Harbor Laboratory, Columbia University College of Physicians and Surgeons, Cornell University/Weill Cornell Medicine, Hospital for Special Surgery, The Jackson Laboratory, Memorial Sloan- Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, NewYork-Presbyterian Hospital, The New York Stem Cell Foundation, New York University, North Shore-LIJ, The Rockefeller University, Roswell Park Cancer Institute and Stony Brook University. For more information, visit: nygenome.org.
